Private drug plans in Canada : expenditure report, 2018-2023. : H82-55/2025E-PDF
"This report provides a comprehensive analysis of trends in prescription drug expenditures from the perspective of Canadian private drug plans. From 2018 to 2023, private pay-direct drug plans experienced a compound annual growth rate of 7.1%, with a significant 12.9% increase in 2023. This growth in 2023 was uneven across its two main components: drug costs (which saw an increase of 14.1%) and dispensing costs (which saw an increase of 4.5%). Over past years, rising expenditures in private plans were consistently driven primarily by significant increases in the use of newer and higher-cost drugs. A comparative analysis with Canadian public drug plans is also included in the report. …"--Executive summary, page iv.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.945863&sl=1
| Ministère/Organisme |
|
|---|---|
| Titre | Private drug plans in Canada : expenditure report, 2018-2023. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Texte numérique |
| Document électronique | |
| Note(s) |
|
| Information sur la publication |
|
| Description | 1 online resource (vi pages, 1 unnumbered page, 41 pages) : colour illustrations |
| ISBN | 9780660747705 |
| Numéro de catalogue |
|
| Descripteurs |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.Détails de la page
- Date de modification :